Vertex Pharmaceuticals (Germany) Price on November 19, 2024

VX1 Stock  EUR 392.50  9.50  2.48%   
If you're considering investing in Vertex Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vertex Pharmaceuticals stands at 392.50, as last reported on the 29th of December, with the highest price reaching 395.50 and the lowest price hitting 391.60 during the day. Vertex Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0212, which indicates the firm had a -0.0212% return per unit of risk over the last 3 months. Vertex Pharmaceuticals Incorporated exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vertex Pharmaceuticals' Variance of 6.22, risk adjusted performance of (0.01), and Coefficient Of Variation of (5,298) to confirm the risk estimate we provide.
  
Vertex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0212

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsVX1

Estimated Market Risk

 2.55
  actual daily
22
78% of assets are more volatile

Expected Return

 -0.05
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Vertex Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vertex Pharmaceuticals by adding Vertex Pharmaceuticals to a well-diversified portfolio.

Vertex Pharmaceuticals Valuation on November 19, 2024

It is possible to determine the worth of Vertex Pharmaceuticals on a given historical date. On November 19, 2024 Vertex was worth 441.15 at the beginning of the trading date compared to the closed value of 435.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vertex Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Vertex Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vertex Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vertex Pharmaceuticals' related companies.
 Open High Low Close Volume
  441.90    441.90    440.00    440.85    88.00  
11/19/2024
  441.15    441.15    435.70    435.70    201.00  
  423.05    424.75    423.05    424.55    85.00  
Backtest Vertex Pharmaceuticals  |  Vertex Pharmaceuticals History  |  Vertex Pharmaceuticals Valuation PreviousNext  
Open Value
441.15
433.50
Downside
435.7
Closing Value
448.80
Upside

Vertex Pharmaceuticals Trading Date Momentum on November 19, 2024

On November 20 2024 Vertex Pharmaceuticals Incorporated was traded for  424.55  at the closing time. The highest daily price throughout the period was 424.75  and the lowest price was  423.05 . The daily volume was 85.0. The net trading volume on 11/20/2024 added to the next day price reduction. The trading price change to closing price of the next trading day was 2.56% . The trading price change to current closing price is 1.23% .
JavaScript chart by amCharts 3.21.1511/19/2024Nov 11Nov 13Nov 15Nov 17Nov 19Nov 21Nov 23Nov 25Nov 27Nov 29430440450460470

Vertex Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Vertex Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vertex Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vertex financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Vertex Pharmaceuticals Stock history

Vertex Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vertex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vertex Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vertex Pharmaceuticals stock prices may prove useful in developing a viable investing in Vertex Pharmaceuticals
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company was founded in 1989 and is headquartered in Boston, Massachusetts. VERTEX PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2500 people.

Vertex Pharmaceuticals Stock Technical Analysis

Vertex Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vertex Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vertex Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Vertex Pharmaceuticals Period Price Range

Low
December 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Vertex Pharmaceuticals Incorporated cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Vertex Pharmaceuticals December 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Vertex Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vertex Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Vertex Pharmaceuticals stock market strength indicators, traders can identify Vertex Pharmaceuticals Incorporated entry and exit signals to maximize returns

Vertex Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Vertex Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Vertex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vertex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk

Trending Assets

22UA
BioNTech SE
108.60  1.40  1.31 
0QF
Moderna
38.92  0.94  2.47 
1FW1
WUXI BIOLOGICS UNSPADR2
4.28  0.02  0.47 
MBG
Mercedes Benz Group
53.33  0.96  1.83